Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 8379294, 5 pages
http://dx.doi.org/10.1155/2016/8379294
Research Article

Assessment of Serum Concentrations of Ghrelin, Obestatin, Omentin-1, and Apelin in Children with Type 1 Diabetes

1Department of Pediatrics, Endocrinology, Diabetology with Subdivision of Cardiology, Medical University of Białystok, Ulica Kilińskiego 1, 15-089 Białystok, Poland
2Department of Pediatrics, Endocrinology, Diabetology with Subdivision of Cardiology, Children’s University Hospital in Białystok, Ulica Waszyngtona 17, 15-274 Białystok, Poland

Received 10 September 2015; Accepted 30 December 2015

Academic Editor: Lucia Malaguarnera

Copyright © 2016 Agnieszka Polkowska et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Sawicka, A. Bossowski, M. Szalecki et al., “Relationship between metabolic parameters and thyroid hormones and the level of gastric peptides in children with autoimmune thyroid diseases,” Journal of Pediatric Endocrinology and Metabolism, vol. 23, no. 4, pp. 345–354, 2010. View at Google Scholar · View at Scopus
  2. A. Bossowski, B. Czarnocka, J. Harasymczuk et al., “Identification of GPR39 receptor and ghrelin receptor in thyroid tissues in paediatric patients with immune and non-immune thyroid diseases,” Hormone Research in Paediatrics, vol. 79, no. 3, pp. 130–136, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. R.-Z. Yang, M.-J. Lee, H. Hu et al., “Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action,” American Journal of Physiology—Endocrinology and Metabolism, vol. 290, no. 6, pp. E1253–E1261, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Fukuhara, M. Matsuda, M. Nishizawa et al., “Visfatin: a protein secreted by visceral fat that mimics the effects of insulin,” Science, vol. 307, no. 5708, pp. 426–430, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. H. J. Yoo, S. Y. Hwang, H. C. Hong et al., “Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes,” Cardiovascular Diabetology, vol. 10, article 103, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. C. M. de Souza Batista, R.-Z. Yang, M.-J. Lee et al., “Omentin plasma levels and gene expression are decreased in obesity,” Diabetes, vol. 56, no. 6, pp. 1655–1661, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Dray, C. Knauf, D. Daviaud et al., “Apelin stimulates glucose utilization in normal and obese insulin-resistant mice,” Cell Metabolism, vol. 8, no. 5, pp. 437–445, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. D. K. Lee, R. Cheng, T. Ngyuen et al., “Characterization of apelin, the ligand for the APJ receptor,” Journal of Neurochemistry, vol. 74, no. 1, pp. 34–41, 2000. View at Google Scholar
  9. M. A. Lazarczyk, M. Lazarczyk, and T. Grzela, “Ghrelin: a recently discovered gut-brain peptide,” International Journal of Molecular Medicine, vol. 12, no. 3, pp. 279–287, 2003. View at Google Scholar · View at Scopus
  10. T. R. Castañeda, J. Tong, R. Datta, M. Culler, and M. H. Tschöp, “Ghrelin in the regulation of body weight and metabolism,” Frontiers in Neuroendocrinology, vol. 31, no. 1, pp. 44–60, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Delzenne, J. Blundell, F. Brouns et al., “Gastrointestinal targets of appetite regulation in humans,” Obesity Reviews, vol. 11, no. 3, pp. 234–250, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. I. Depoortere, T. Thijs, D. Moechars, B. De Smet, L. Ver Donck, and T. L. Peeters, “Effect of peripheral obestatin on food intake and gastric emptying in ghrelin-knockout mice,” British Journal of Pharmacology, vol. 153, no. 7, pp. 1550–1557, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Ikezaki, H. Hosoda, K. Ito et al., “Fasting plasma ghrelin levels are negatively correlated with insulin resistance and PAI-1, but not with leptin, in obese children and adolescents,” Diabetes, vol. 51, no. 12, pp. 3408–3411, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Tapan, E. Tascilar, A. Abaci et al., “Decreased plasma apelin levels in pubertal obese children,” Journal of Pediatric Endocrinology and Metabolism, vol. 23, no. 10, pp. 1039–1046, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Ziora, J. Oświecimska, E. Świetochowska et al., “Assessment of serum apelin levels in girls with anorexia nervosa,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 6, pp. 2935–2941, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Zamrazilová, V. Hainer, D. Sedláčková et al., “Plasma obestatin levels in normal weight, obese and anorectic women,” Physiological Research, vol. 57, supplement 1, pp. S49–S55, 2008. View at Google Scholar · View at Scopus
  17. T. Reinehr, J. Woelfle, and C. L. Roth, “Lack of association between apelin, insulin resistance, cardiovascular risk factors, and obesity in children: a longitudinal analysis,” Metabolism: Clinical and Experimental, vol. 60, no. 9, pp. 1349–1354, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. L. H. Duntas, J. Orgiazzi, and G. Brabant, “The interface between thyroid and diabetes mellitus,” Clinical Endocrinology, vol. 75, no. 1, pp. 1–9, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. H. Cho, M. E. Craig, and K. C. Donaghue, “Puberty as an accelerator for diabetes complications,” Pediatric Diabetes, vol. 15, no. 1, pp. 18–26, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. W. Modrzejewski and W. J. Musiał, “Old and new cardiovascular risk factor—how to stop an epidemic of atherosclerosis Part1. Classical risks,” Forum Zaburzeń Metabolicznych, vol. 1, no. 2, pp. 106–114, 2010. View at Google Scholar
  21. R.-E. W. Kavey, S. R. Daniels, R. M. Lauer, D. L. Atkins, L. L. Hayman, and K. Taubert, “American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood,” Circulation, vol. 107, no. 11, pp. 1562–1566, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Giannini, A. Mohn, F. Chiarelli, and C. J. H. Kelnar, “Macrovascular angiopathy in children and adolescents with type 1 diabetes,” Diabetes/Metabolism Research and Reviews, vol. 27, no. 5, pp. 436–460, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Broda, “Zapobiegać miażdżycy w dzieciństwie, aby zachować zdrowie w dalszych latach życia,” Kardiologia Polska, vol. 69, no. 6, pp. 546–547, 2011. View at Google Scholar · View at Scopus
  24. C. Giannattasio, M. Failla, A. Piperno et al., “Early impairment of large artery structure and function in Type I diabetes mellitus,” Diabetologia, vol. 42, no. 8, pp. 987–994, 1999. View at Publisher · View at Google Scholar · View at Scopus
  25. A. G. Japp, N. L. Cruden, G. Barnes et al., “Acute cardiovascular effects of apelin in humans: potential role in patients with chronic heart failure,” Circulation, vol. 121, no. 16, pp. 1818–1827, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. E. A. Ashley, J. Powers, M. Chen et al., “The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo,” Cardiovascular Research, vol. 65, no. 1, pp. 73–82, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. F.-J. Shang, J.-P. Wang, X.-T. Liu et al., “Serum omentin-1 levels are inversely associated with the presence and severity of coronary artery disease in patients with metabolic syndrome,” Biomarkers, vol. 16, no. 8, pp. 657–662, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. M. M. Malagón, R. M. Luque, E. Ruiz-Guerrero et al., “Intracellular signaling mechanisms mediating ghrelin-stimulated growth hormone release in somatotropes,” Endocrinology, vol. 144, no. 12, pp. 5372–5380, 2003. View at Publisher · View at Google Scholar · View at Scopus